All lobbying filings

Aviva Strategies (FKA MGB Consulting)

Aviva Strategies (FKA MGB Consulting) filed a Q3 report for Element Biosciences on October 19, 2026, reporting $44,000 in lobbying income.

Lobbying for Element Biosciences · Biotechnology

As filed: AVIVA STRATEGIES (FKA MGB CONSULTING) for ELEMENT BIOSCIENCES.

All filings by Aviva Strategies (FKA MGB Consulting) · Everything Element Biosciences has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$44,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025

Medical/Disease Research/Clinical Labs

- National Security Commission on Emerging Biotechnology

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.